Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trudell, R. G.
Right arrow Articles by Griggs, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trudell, R. G.
Right arrow Articles by Griggs, R. C.
NEUROLOGY 1987;37:488
© 1987 American Academy of Neurology

Acetazolamide-responsive myotonia congenita

Randall G. Trudell, MD, Kenneth K. Kaiser, BS and Robert C. Griggs, MD

Department of Neurology (Drs. Trudell and Griggs), University of Rochester, Rochester, NY, and the Department of Neurology (Mr. Kaiser), Washington University, St. Louis, MO.

We have studied 14 patients from a kindred with an auto-somal dominant form of myotonia, with features differing from most cases of autosomal dominant or recessive myotonia congenita. All patients had painful muscle stiffness that was provoked by fasting and oral potassium administration and was relieved by carbohydrate-containing foods. Muscle biopsies showed the presence of type 1, 2A, and 2B fibers, as opposed to the absence of type 2B fibers seen in some patients with myotonia congenita. Acetazolamide was dramatically effective in alleviating myotonia in all patients and was more effective than other antimyotonic agents.

Address correspondence and reprint requests to Dr. Griggs, Department of Neurology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 673, Rochester, NY 14642.

Presented in part at the thirty-seventh annual meeting of the American Academy of Neurology, Dallas, TX, April 1985.

Supported in part by grants from the USPHS Division of Research Resources (RR 00044) and the Muscular Dystrophy Association. Dr. Trudell was supported by a Clinical Fellowship from the Muscular Dystrophy Association.

Received April 11, 1986. Accepted for publication in final form June 24, 1986.




This article has been cited by other articles:


Home page
NeurologyHome page
E. Rossignol, J. Mathieu, I. Thiffault, M. Tetreault, M. -J. Dicaire, N. Chrestian, N. Dupre, J. Puymirat, and B. Brais
A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians
Neurology, November 13, 2007; 69(20): 1937 - 1941.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
J. Weinberg, L. A. Curl, R. W. Kuncl, and E. G. McFarland
Occult Presentation of Myotonia Congenita in a 15-Year-Old Athlete
Am. J. Sports Med., July 1, 1999; 27(4): 529 - 531.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R. W Orrell, K. Jurkat-Rott, F. Lehmann-Horn, and R. J M Lane
Familial cramp due to potassium-aggravated myotonia
J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 569 - 572.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N. Celebisoy, Z. Colakoglu, Y. Akbaba, and N. Yuceyar
Continuous muscle fibre activity: a case treated with acetazolamide
J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 256 - 258.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. J. Ptacek, K. J. Johnson, and R. C. Griggs
Genetics and Physiology of the Myotonic Muscle Disorders
N. Engl. J. Med., February 18, 1993; 328(7): 482 - 489.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.